Dulaglutide (Trulicity) in 2026: Newest Evidence on Weight, Heart Protection, and How It Compares to Semaglutide and Tirzepatide
TL;DR: Dulaglutide is a once-weekly GLP-1 injection for type 2 diabetes with proven heart and kidney benefits. New 2026 data show it remains noninferior to
